[HTML] frontiersin.org

[HTML][HTML] Combining EGFR-TKI with SAHA overcomes EGFR-TKI-acquired resistance by reducing the protective autophagy in non-small cell lung cancer

P Cao, Y Li, R Shi, Y Yuan, H Gong, G Zhu… - Frontiers in …, 2022 - frontiersin.org
Nowadays, lung cancer has the highest mortality worldwide. The emergence of epidermal
growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) has greatly improved the …
被引用次数：9 相关文章
[HTML] nih.gov

[HTML][HTML] Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer

P Cao, Y Li, R Shi, Y Yuan, H Gong, G Zhu… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Nowadays, lung cancer has the highest mortality worldwide. The emergence of epidermal
growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) has greatly improved the …

Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer.

P Cao, Y Li, R Shi, Y Yuan, H Gong, G Zhu… - Frontiers in …, 2022 - europepmc.org
Nowadays, lung cancer has the highest mortality worldwide. The emergence of epidermal
growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) has greatly improved the …

Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer

P Cao, Y Li, R Shi, Y Yuan, H Gong… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Nowadays, lung cancer has the highest mortality worldwide. The emergence of epidermal
growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) has greatly improved the …

Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer

P Cao, Y Li, R Shi, Y Yuan, H Gong… - … -Molecule Agents in …, 2022 - books.google.com
Nowadays, lung cancer has the highest mortality worldwide. The emergence of epidermal
growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) has greatly improved the …

Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer.

P Cao, Y Li, R Shi, Y Yuan, H Gong, G Zhu… - Frontiers in …, 2022 - europepmc.org
Nowadays, lung cancer has the highest mortality worldwide. The emergence of epidermal
growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) has greatly improved the …